OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 02, 2017
New ADC therapies must overcome manufacturing challenges to reach market.
As commercial manufacturing considers single-use materials, a look shows how industry moved to the technology.
The more pharma science and technology change, the more business and policy concerns stay the same.
Polymers and surfactants impact stability and long-term performance.
FDA is working with manufacturers to encourage industry innovation.
Biotech-based therapies and a move to single-use processes highlight recent industry changes.
ISPE measures impact of biotechnology and globalization on personalized medicine.
Advancements in cell culture and protein technology have opened the door for new therapies.
Pharma’s test of continuous manufacturing is starting with oral solid-dosage forms.
Greater transparency and reliability of information are needed in the quality assessments of biosimilars.